社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Veradermics, Inc.(MANE)
盘后
50.49
-0.83
-1.62%
18:03 EDT
51.32
+2.76
+5.68%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
防脱发企业VeraDermics上市：市值13亿美元 9个月亏4815万美元
雷递网 · 02-07
防脱发企业VeraDermics上市：市值13亿美元 9个月亏4815万美元
植发药物开发商Veradermics(MANE.US)IPO定价17美元/股 上市首日暴涨122%
智通财经 · 02-05
植发药物开发商Veradermics(MANE.US)IPO定价17美元/股 上市首日暴涨122%
Veradermics Inc. 上调首次公开募股规模，以每股17.00美元定价发行1500万股普通股
美股速递 · 02-04
Veradermics Inc. 上调首次公开募股规模，以每股17.00美元定价发行1500万股普通股
礼来公司表示有意以IPO价格收购Veradermics最多4.9%流通股
美股速递 · 02-03
礼来公司表示有意以IPO价格收购Veradermics最多4.9%流通股
礼来收购Veradermics普通股将不受承销商锁定期协议约束
美股速递 · 02-03
礼来收购Veradermics普通股将不受承销商锁定期协议约束
“秃头经济”新玩家：生发药企Veradermics(MANE.US)拟IPO募资2.14亿美元，市值冲刺5.34亿
智通财经 · 01-29
“秃头经济”新玩家：生发药企Veradermics(MANE.US)拟IPO募资2.14亿美元，市值冲刺5.34亿
公司概况
公司名称
Veradermics, Inc.
所属市场
NYSE
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.veradermics.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
VeraDermics, Incorporated成立于2019年10月5日，最初位于德克萨斯州，后于2021年9月15日转换为特拉华州公司。这家由皮肤科医生创办的晚期临床阶段生物制药公司专注于开发针对普遍存在的美学和皮肤病状况的创新疗法。VeraDermics主要致力于解决影响美国众多个体的模式性脱发（PHL）治疗挑战。公司目前正在推进其主要候选药物VDPHL01，这是一种口服非激素治疗，旨在优化毛发生长，同时最小化与传统疗法相关的副作用。VeraDermics正在进行关键临床试验，以支持监管审批，并通过其针对性的治疗方法，旨在改变PHL的管理方式。
02-05
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
02-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-03
[补充]招股说明书
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
01-28
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01-09
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
分时
5日
日
周
月
数据加载中...
最高
52.60
今开
48.93
量比
2.29
最低
48.93
昨收
48.56
换手率
2.67%
热议股票
{"pagemeta":{"title":"Veradermics, Inc.(MANE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Veradermics, Inc.(MANE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Veradermics, Inc.,MANE,Veradermics, Inc.股票,Veradermics, Inc.股票老虎,Veradermics, Inc.股票老虎国际,Veradermics, Inc.行情,Veradermics, Inc.股票行情,Veradermics, Inc.股价,Veradermics, Inc.股市,Veradermics, Inc.股票价格,Veradermics, Inc.股票交易,Veradermics, Inc.股票购买,Veradermics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Veradermics, Inc.(MANE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Veradermics, Inc.(MANE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"news","symbol":"MANE","data":{"stockData":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":51.32,"timestamp":1773086400000,"preClose":48.56,"halted":0,"volume":466380,"hourTrading":{"tag":"盘后","latestPrice":50.4867,"preClose":51.32,"latestTime":"18:03 EDT","volume":442,"amount":22410.08,"timestamp":1773093801951,"change":-0.8333,"changeRate":-0.016237,"amplitude":0.016237},"delay":0,"changeRate":0.05683690280065894,"floatShares":17459900,"shares":37338700,"eps":-1.534,"marketStatus":"未开盘","change":2.76,"latestTime":"03-09 16:00:00 EDT","open":48.93,"high":52.6,"low":48.93,"amount":23971201.64892,"amplitude":0.075577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.534,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773129600000},"marketStatusCode":0,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":48.56,"preHourTrading":{"tag":"盘前","latestPrice":49.69,"preClose":48.56,"latestTime":"09:04 EDT","volume":13,"amount":644.56002,"timestamp":1773061443851,"change":1.13,"changeRate":0.02327,"amplitude":0.009679},"postHourTrading":{"tag":"盘后","latestPrice":50.4867,"preClose":51.32,"latestTime":"18:03 EDT","volume":442,"amount":22410.08,"timestamp":1773093801951,"change":-0.8333,"changeRate":-0.016237,"amplitude":0.016237},"volumeRatio":2.288047},"tweetData":null,"newsData":{"listData":[{"id":"2609514045","title":"防脱发企业VeraDermics上市：市值13亿美元 9个月亏4815万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609514045","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609514045?lang=zh_cn&edition=full","pubTime":"2026-02-07 06:10","pubTimestamp":1770415817,"startTime":"0","endTime":"0","summary":"专注于皮肤病领域的生物制药公司VeraDermics(NYSE:MANE)日前在美股上市，发行价为17美元，发行1508万股，募资总额为2.56亿美元。截至今日收盘，VeraDermics股价为37.16美元，市值为13亿美元。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260207/6390604141325207394345179.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260207/6390604141325207394345179.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32603/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["MANE"],"gpt_icon":0},{"id":"2609634894","title":"植发药物开发商Veradermics(MANE.US)IPO定价17美元/股 上市首日暴涨122%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609634894","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609634894?lang=zh_cn&edition=full","pubTime":"2026-02-05 09:18","pubTimestamp":1770254331,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，植发药物开发商Veradermics上市首日收涨逾122%，报37.75美元，远高于其首次公开募股的发行价17美元。该公司在IPO中筹集了2.563亿美元。知情人士称，此次扩大发行规模后的IPO获得了数倍于发行量的超额认购。根据申报文件，Wellington Management曾表示有意按照IPO价格认购最多3000万美元的股份。据悉，Veradermics正在研发一种适用于男女性雄激素性脱发的口服非激素疗法。数据显示，Veradermics 在截至去年9月30日的九个月内净亏损为4810万美元，而上年同期的净亏损为2080万美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"植发药物开发商Veradermics(MANE.US)IPO定价17美元/股 上市首日暴涨122%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MANE"],"gpt_icon":0},{"id":"1174794357","title":"Veradermics Inc. 上调首次公开募股规模，以每股17.00美元定价发行1500万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1174794357","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174794357?lang=zh_cn&edition=full","pubTime":"2026-02-04 10:58","pubTimestamp":1770173894,"startTime":"0","endTime":"0","summary":"Veradermics Inc. 宣布，其首次公开募股（IPO）的最终定价为每股17.00美元。此次发行规模已上调至1500万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE"],"gpt_icon":0},{"id":"1111688428","title":"礼来公司表示有意以IPO价格收购Veradermics最多4.9%流通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1111688428","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111688428?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:18","pubTimestamp":1770117533,"startTime":"0","endTime":"0","summary":"生物科技公司Veradermics, Inc.近日披露，全球制药巨头礼来公司已表明投资意向，计划在公司完成首次公开募股后，以发行价购入不超过总股本4.9%的普通股。这一战略投资若最终落地，将显著强化两家公司在皮肤病治疗领域的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1989771016.USD","IE00B775H168.HKD","BK4534","LU2237443549.SGD","LU2089984988.USD","LU1720051108.HKD","LU1064131342.USD","SG9999001176.USD","LU2236285917.USD","LU1035775433.USD","SG9999014914.USD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4533","LU2746668974.SGD","LU2265009873.SGD","BK4585","BK4581","LU2237443978.SGD","LU0320765059.SGD","IE0004445239.USD","IE00B1XK9C88.USD","LU1551013342.USD","LU2471134523.USD","SG9999017495.SGD","LU0708995401.HKD","LU0353189680.USD","SGXZ99366536.SGD","LU1868836757.USD","LU2896262040.SGD","LU0943347566.SGD","LU2089284900.SGD","LU2168564149.EUR","LU1868837300.USD","LU1061106388.HKD","LU1868836591.USD","LU2360106947.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","LU2461242641.AUD","LU1023059063.AUD","LU1366192091.USD","LU2237443895.HKD","IE00BJJMRX11.SGD","IE0002141913.USD","LU1093756168.USD","LU2471134796.USD","IE0004445015.USD","IE00BN29S564.USD","LU0109394709.USD","LU2063271972.USD","LU1551013425.SGD","LU2746668461.USD","LU0385154629.USD","IE0009355771.USD","LU2028103732.USD","LU1814569148.SGD","LU2168564065.EUR","SG9999015945.SGD","BK4599","LU2462157665.USD","SG9999018857.SGD","SGXZ31699556.SGD","IE00B2B36J28.USD","LU0354030511.USD","LU1868836914.USD","LU0471298777.SGD","LU0058720904.USD","LU0882574055.USD","LU1720051017.SGD","SG9999014880.SGD","LU1988902786.USD","LU0466842654.USD","LU1804176565.USD","IE00BK4W5L77.USD","LU2237438978.USD","LU2417539215.USD","LU0158827948.USD","LU0320765992.SGD","LU1712237335.SGD","LU2168564222.USD","LU0109391861.USD","LU1291159041.SGD","LU2456880835.USD","LU0266013472.USD","LU0823434583.USD","LU2237443382.USD","IE00BJJMRZ35.SGD","SG9999014898.SGD","LU2361044865.SGD","LU1917777945.USD","LU0640476718.USD","LU1548497426.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU2211815571.USD","LU0471298694.HKD","LU1093756325.SGD","LU0353189763.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SGXZ81514606.USD","SG9999015978.USD","LU1069344957.HKD","LU0122379950.USD","LU1232071149.USD","LU2237443622.USD","LU2361045086.USD","LU2087625088.SGD","SG9999001176.SGD","LU0683600562.USD","LU0316494557.USD","MANE","SGXZ57979304.SGD","LU2168563687.JPY","LU0256863902.USD","LU0787776722.HKD","LU0820561818.USD","LU2168564495.EUR","SG9999015986.USD","LU0203202063.USD","LU2552382215.SGD","LU2471134879.HKD","LU2324357040.USD","BK4516","LU2361044949.HKD","LU0203201768.USD","IE00BK4W5M84.HKD","SG9999013999.USD","LU2106854487.HKD","LU2750360641.GBP","LU0106261372.USD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU1623119135.USD","LU0234572021.USD","LU0823416689.USD","LU2491050071.SGD","LU2491049909.HKD","LU0006306889.USD","LU1974910355.USD","LU0079474960.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU2089283258.USD","IE00BFSS8Q28.SGD","LU2264538146.SGD","IE00BWXC8680.SGD","BK4588","LU0456855351.SGD","LU0820561909.HKD","LU0097036916.USD","LU2111349929.HKD","LU2271345857.HKD","LU2471134952.CNY","SGXZ51526630.SGD","LU0061475181.USD","LU2023251221.USD","LU0672654240.SGD","LU0198837287.USD","LU2468319806.SGD","LU2750360997.AUD","SG9999018865.SGD","LU2237443465.HKD","LU0786609619.USD","LU1868837136.USD","LU0210536198.USD","IE00BFSS7M15.SGD","LU2602419157.SGD","LU0096364046.USD","LU0323591593.USD","LU1983299246.USD","LU1280957306.USD","LU1267930730.SGD","LU0354030438.USD","IE00BJJMRY28.SGD","LU0158827781.USD","LU2552382058.USD","IE00BKPKM429.USD","GB00BDT5M118.USD","BK4007","LU2491050154.USD","LU0094547139.USD","LU0823434740.USD","LU0882574139.USD","LU2023250504.SGD","LU0225283273.USD","LU0417517546.SGD","LU2357305700.SGD","LU0114720955.EUR","IE00BKDWB100.SGD","LLY","SG9999015952.SGD","LU1127390331.HKD","LU0689472784.USD","LU1323610961.USD","SG9999014906.USD","LU2552382132.HKD","LU0256863811.USD","LU2108987350.USD"],"gpt_icon":0},{"id":"1197029226","title":"礼来收购Veradermics普通股将不受承销商锁定期协议约束","url":"https://stock-news.laohu8.com/highlight/detail?id=1197029226","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197029226?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:18","pubTimestamp":1770117529,"startTime":"0","endTime":"0","summary":"根据最新披露的协议条款，Veradermics公司（Veradermics, Inc.）与礼来公司（Eli Lilly）达成的普通股收购交易出现重大突破——这些拟被收购的股份将完全豁免于承销商设置的锁定期协议限制。这意味着礼来在完成收购后即可自由处置所持股份，无需遵守常规IPO后禁止抛售的约束性条款。该安排显著区别于常规股权投资模式，反映出交易双方对股权流动性的特殊考量，可能为后续战略合作奠定灵活基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","LU0820561909.HKD","LU0889565916.HKD","LU0198837287.USD","LU0456855351.SGD","LU0256863811.USD","BK4516","IE00BFSS8Q28.SGD","LU2471134952.CNY","SG9999014880.SGD","LU2106854487.HKD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1988902786.USD","LU2471134879.HKD","LU2211815571.USD","LU2108987350.USD","IE00BK4W5L77.USD","LU0354030438.USD","LU0158827948.USD","IE00B4JS1V06.HKD","LU2168564495.EUR","LU1868836591.USD","IE00BJJMRY28.SGD","SG9999001176.SGD","LU2417539215.USD","LU0106261372.USD","LU0471298777.SGD","LU2087625088.SGD","LU2750360997.AUD","LU1868837136.USD","LU0882574055.USD","LU0471298694.HKD","LU2265009873.SGD","LU1069344957.HKD","LU2552382215.SGD","SG9999001176.USD","LU2471134796.USD","LU0882574139.USD","LU1917777945.USD","LU1023059063.AUD","LU1057294990.SGD","LU1061106388.HKD","LU0708995401.HKD","LU1366192091.USD","LU2112291526.USD","BK4581","LU0234572021.USD","LU0061475181.USD","SGXZ99366536.SGD","LU0316494557.USD","LU0109391861.USD","LU2456880835.USD","LU2264538146.SGD","LU0689472784.USD","LU1064131342.USD","IE00BK4W5M84.HKD","LU1712237335.SGD","LU2089284900.SGD","LU1035775433.USD","LU1720051108.HKD","LU2023251221.USD","LU0323591593.USD","SG9999015978.USD","LU0354030511.USD","LU0158827781.USD","SGXZ31699556.SGD","IE00B1XK9C88.USD","LU0432979614.USD","LU0096364046.USD","SGXZ51526630.SGD","LU0114720955.EUR","SG9999017495.SGD","SGXZ81514606.USD","BK4588","LU2023250504.SGD","LU0353189680.USD","IE00BWXC8680.SGD","LU2360106947.USD","LU0058720904.USD","LU0210536198.USD","LU2896262040.SGD","LU1551013342.USD","LU2602419157.SGD","LU1127390331.HKD","LU0266013472.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU2750360641.GBP","IE00B775H168.HKD","LU0683600562.USD","LU0225283273.USD","LU2237443895.HKD","IE00B2B36J28.USD","LU0943347566.SGD","LU2089283258.USD","IE00BN29S564.USD","SG9999015945.SGD","LU2746668974.SGD","LU2237443978.SGD","LU1720051017.SGD","SGXZ57979304.SGD","LU0238689110.USD","LU2357305700.SGD","LU1623119135.USD","LU1983299246.USD","LU2461242641.AUD","LU0289739699.SGD","LU1093756168.USD","BK4534","LU0203202063.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU2491050154.USD","GB00BDT5M118.USD","SG9999014914.USD","LU0353189763.USD","BK4007","LU0203201768.USD","LU0256863902.USD","LU2491049909.HKD","LU0320765059.SGD","LU2361044865.SGD","LU1291159041.SGD","LU2361044949.HKD","LU1280957306.USD","LU0787776722.HKD","LU0640476718.USD","LU0079474960.USD","IE00BFSS7M15.SGD","LU1804176565.USD","LU1868836914.USD","LU0320765992.SGD","LU1323610961.USD","LU2237443465.HKD","LU0122379950.USD","LU0823434740.USD","LU1974910355.USD","LU2237438978.USD","LU2491050071.SGD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0466842654.USD","LU2089984988.USD","SG9999015986.USD","LU2746668461.USD","LU2552382132.HKD","LU2237443382.USD","LU2237443549.SGD","LU2063271972.USD","LU2471134523.USD","SG9999014906.USD","IE0009355771.USD","LU0385154629.USD","LU2552382058.USD","LU2168564222.USD","BK4599","LU2237443622.USD","LU0006306889.USD","LU2324357040.USD","IE00B1BXHZ80.USD","LU0097036916.USD","LU1551013425.SGD","LU0823416689.USD","MANE","LU2168564149.EUR","LU2236285917.USD","LU0786609619.USD","LU1232071149.USD","LU0820561818.USD","IE0004445015.USD","LU2028103732.USD","LU1989771016.USD","SG9999013999.USD","IE00BJJMRX11.SGD","SG9999018857.SGD","SG9999018865.SGD","BK4585","IE0004445239.USD","LU2462157665.USD","LU1093756325.SGD","SG9999014898.SGD","IE00BJJMRZ35.SGD","IE00BKPKM429.USD","LU0094547139.USD","LU0823434583.USD","LU1814569148.SGD","LU1548497426.USD","SG9999015952.SGD","IE0002141913.USD","IE0005OL40V9.USD","LU0417517546.SGD","LU1267930730.SGD","LU1868837300.USD","LU0672654240.SGD","BK4533","LU2111349929.HKD","LU2271345857.HKD","IE00BFTCPJ56.SGD","LU2168564065.EUR","IE00BJLML261.HKD"],"gpt_icon":0},{"id":"2607777957","title":"“秃头经济”新玩家：生发药企Veradermics(MANE.US)拟IPO募资2.14亿美元，市值冲刺5.34亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2607777957","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607777957?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:30","pubTimestamp":1769657450,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，致力于毛发修复的生物制药公司 Veradermics Inc. 正寻求通过 IPO 筹集高达 2.136 亿美元的资金，以推进其生发口服药的商业化。根据文件中列出的发行后总股本计算，若按定价区间上限执行，Veradermics 的市值将达到约 5.34 亿美元。根据申报文件，Veradermics 在截至 9 月 30 日的九个月内净亏损为 4810 万美元，而去年同期的净亏损为 2080 万美元。Veradermics 的非激素脱发实验性治疗药物正处于临床后期试验阶段。此次 IPO 此前，Veradermics 曾于 10 月通过 C 轮融资筹集了 1.5 亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"“秃头经济”新玩家：生发药企Veradermics(MANE.US)拟IPO募资2.14亿美元，市值冲刺5.34亿","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MANE"],"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20705792","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828026005859-MANE","pdf_url":"","pub_time":1770267600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"MANE","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/0001628280-26-005859-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/veradermicsincs-8.htm","primary":true,"translateUrl":"","linkName":"veradermicsincs-8.htm","type":"S-8","id":"NTFILE3W1Ji8qJEj6hxYbQ","market":"us","size":70377},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILE3ezwfaKtGeeocTJX","market":"us","size":26434},{"description":"EX-4.4","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/exhibit44-sx8.htm","primary":false,"translateUrl":"","linkName":"exhibit44-sx8.htm","type":"EX-4.4","id":"NTFILE7gA9W6uVEKoCoWRr","market":"us","size":114417},{"description":"EX-5.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/exhibit51-sx8.htm","primary":false,"translateUrl":"","linkName":"exhibit51-sx8.htm","type":"EX-5.1","id":"NTFILE3iexvZCvd9N788m5","market":"us","size":9696},{"description":"EX-23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/exhibit231-sx8.htm","primary":false,"translateUrl":"","linkName":"exhibit231-sx8.htm","type":"EX-23.1","id":"NTFILE6ghdat7VchmfREkt","market":"us","size":1887},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005859/ropesgray.jpg","primary":false,"translateUrl":"","linkName":"ropesgray.jpg","type":"GRAPHIC","id":"NTFILE4yJUvQp1DhVEf4ua","market":"us","size":48207}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2026-02-05 13:00","pubTimestamp":1770267600,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20705357","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828026005800-MANE","pdf_url":"","pub_time":1770267600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MANE","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/0001628280-26-005800-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/exhibit31-closing8xk.htm","primary":true,"translateUrl":"","linkName":"exhibit31-closing8xk.htm","type":"EX-3.1","id":"NTFILEHKhnAH23Mc34mdpa","market":"us","size":54031},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/veradermicsincclosing8-k.htm","primary":false,"translateUrl":"","linkName":"veradermicsincclosing8-k.htm","type":"8-K","id":"NTFILE9PRb6KJm7afciGRe","market":"us","size":27608},{"description":"EX-3.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/exhibit32-closing8xk.htm","primary":false,"translateUrl":"","linkName":"exhibit32-closing8xk.htm","type":"EX-3.2","id":"NTFILE75vVJv3EL2r4Trcv","market":"us","size":88634}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-05 13:00","pubTimestamp":1770267600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.03项：公司章程或章程的修订；财政年度的变化；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20695313","market":"us","labels":[],"media":"sec.gov","original_id":"AN182763526000005-MANE","pdf_url":"","pub_time":1770094800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses","symbol":"MANE","title":"Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses","titleType":"[补充]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1827635/000182763526000005/0001827635-26-000005-index.htm","us_notice_code":"Form FWP","us_title_en":"Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FWP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000182763526000005/veradermics-fwp.htm","primary":true,"translateUrl":"","linkName":"veradermics-fwp.htm","type":"FWP","id":"NTFILEEAQgmhHrrj8Yorgv","market":"us","size":9070},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000182763526000005/image_0a.jpg","primary":false,"translateUrl":"","linkName":"image_0a.jpg","type":"GRAPHIC","id":"NTFILEHoSdSa7uAMH2rW5Q","market":"us","size":8428}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Supp]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[补充]招股说明书","pubTime":"2026-02-03 13:00","pubTimestamp":1770094800,"title_zh":"Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20671131","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828026003764-MANE","pdf_url":"","pub_time":1769576400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"MANE","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/0001628280-26-003764-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/veradermicsincs-1a.htm","primary":true,"translateUrl":"","linkName":"veradermicsincs-1a.htm","type":"S-1/A","id":"NTFILEECiGwGpXM6KYCecf","market":"us","size":2777959},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILEFjLPFxZrjYuogqru","market":"us","size":27979},{"description":"EX-1.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit11-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit11-sx1a2.htm","type":"EX-1.1","id":"NTFILEGCUutPRjhjixxxfX","market":"us","size":363868},{"description":"EX-3.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit31-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit31-sx1a2.htm","type":"EX-3.1","id":"NTFILE5dkcyiPUSzwiqLCW","market":"us","size":53076},{"description":"EX-3.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit32-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit32-sx1a2.htm","type":"EX-3.2","id":"NTFILECpAWxBYsEaopSiYk","market":"us","size":88629},{"description":"EX-4.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit41-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit41-sx1a2.htm","type":"EX-4.1","id":"NTFILEGJgjdxz3Cw65ZX4H","market":"us","size":5009},{"description":"EX-4.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit42-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit42-sx1a2.htm","type":"EX-4.2","id":"NTFILE9Su93yXoBBgnHRLf","market":"us","size":420533},{"description":"EX-5.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit51-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit51-sx1a2.htm","type":"EX-5.1","id":"NTFILE9CibP3HpgpMc9ASq","market":"us","size":9379},{"description":"EX-10.3","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit103-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit103-sx1a2.htm","type":"EX-10.3","id":"NTFILEFNwa5zSfsFsfTvvY","market":"us","size":193171},{"description":"EX-10.4","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit104-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit104-sx1a2.htm","type":"EX-10.4","id":"NTFILEHJPYkNwLBKVe4Mzf","market":"us","size":452464},{"description":"EX-10.5","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit105-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit105-sx1a2.htm","type":"EX-10.5","id":"NTFILEEbxMTKUnoa9aUtPj","market":"us","size":452730},{"description":"EX-10.6","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit106-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit106-sx1a2.htm","type":"EX-10.6","id":"NTFILEEznjiEMnct2tpu8k","market":"us","size":80776},{"description":"EX-10.7","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit107-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit107-sx1a2.htm","type":"EX-10.7","id":"NTFILE5iXiqcp3QsxpNsvo","market":"us","size":115224},{"description":"EX-10.8","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit108-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit108-sx1a2.htm","type":"EX-10.8","id":"NTFILE2bWoH9szLqbQnLor","market":"us","size":29006},{"description":"EX-10.9","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit109-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit109-sx1a2.htm","type":"EX-10.9","id":"NTFILE8BwxjgnaNws8AV4y","market":"us","size":26112},{"description":"EX-10.10","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1010-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1010-sx1a2.htm","type":"EX-10.10","id":"NTFILEBxsHSQm5XHACdbgi","market":"us","size":27978},{"description":"EX-10.11","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1011-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1011-sx1a2.htm","type":"EX-10.11","id":"NTFILEHuud64R7DwVaaxRA","market":"us","size":36677},{"description":"EX-10.12","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1012-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1012-sx1a2.htm","type":"EX-10.12","id":"NTFILE8Q7eZ8fF8UyJuZ3z","market":"us","size":108850},{"description":"EX-10.13","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1013-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1013-sx1a2.htm","type":"EX-10.13","id":"NTFILE2QtZXE4eWdEETpjR","market":"us","size":105277},{"description":"EX-10.14","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1014-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1014-sx1a2.htm","type":"EX-10.14","id":"NTFILEGHeEjksxvRPua1Mq","market":"us","size":101896},{"description":"EX-10.15","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit1015-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit1015-sx1a2.htm","type":"EX-10.15","id":"NTFILEDdeXsczP6ExPamAa","market":"us","size":108837},{"description":"EX-21.1","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit211-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit211-sx1a2.htm","type":"EX-21.1","id":"NTFILE6oEDuC41wBxEJynY","market":"us","size":1779},{"description":"EX-23.1","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/exhibit231-sx1a2.htm","primary":false,"translateUrl":"","linkName":"exhibit231-sx1a2.htm","type":"EX-23.1","id":"NTFILE8UbEQua5RpM8DgfW","market":"us","size":1927},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business10ba.jpg","primary":false,"translateUrl":"","linkName":"business10ba.jpg","type":"GRAPHIC","id":"NTFILE7DWWtQZu4Ss5V8fh","market":"us","size":360204},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business11ba.jpg","primary":false,"translateUrl":"","linkName":"business11ba.jpg","type":"GRAPHIC","id":"NTFILE5eTYsJQcb28rNYir","market":"us","size":427541},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business12ba.jpg","primary":false,"translateUrl":"","linkName":"business12ba.jpg","type":"GRAPHIC","id":"NTFILEFc76QUE64ADXX5WB","market":"us","size":395689},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business13b.jpg","primary":false,"translateUrl":"","linkName":"business13b.jpg","type":"GRAPHIC","id":"NTFILEJ1834kU2bd86Uceo","market":"us","size":3085536},{"description":"","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business14ba.jpg","primary":false,"translateUrl":"","linkName":"business14ba.jpg","type":"GRAPHIC","id":"NTFILE3f2bBg1d38N6W8wk","market":"us","size":3309624},{"description":"","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business15ba.jpg","primary":false,"translateUrl":"","linkName":"business15ba.jpg","type":"GRAPHIC","id":"NTFILEHDA82UtckvcKVH4g","market":"us","size":3290382},{"description":"","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business16ba.jpg","primary":false,"translateUrl":"","linkName":"business16ba.jpg","type":"GRAPHIC","id":"NTFILECaPZ543hxHxcpR8R","market":"us","size":3769597},{"description":"","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business17ba.jpg","primary":false,"translateUrl":"","linkName":"business17ba.jpg","type":"GRAPHIC","id":"NTFILE8qFYPzUuY8ePKHXw","market":"us","size":2485777},{"description":"","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business18ba.jpg","primary":false,"translateUrl":"","linkName":"business18ba.jpg","type":"GRAPHIC","id":"NTFILEBoobish9H27ZeNDe","market":"us","size":1225136},{"description":"","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business19ba.jpg","primary":false,"translateUrl":"","linkName":"business19ba.jpg","type":"GRAPHIC","id":"NTFILEH1NsB6pRgntAY24i","market":"us","size":1234523},{"description":"","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business20ba.jpg","primary":false,"translateUrl":"","linkName":"business20ba.jpg","type":"GRAPHIC","id":"NTFILE28jTEENmYvoNG2ag","market":"us","size":1048748},{"description":"","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business3b.jpg","primary":false,"translateUrl":"","linkName":"business3b.jpg","type":"GRAPHIC","id":"NTFILE9ieR7gK8NuvpAZsc","market":"us","size":195077},{"description":"","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business4ca.jpg","primary":false,"translateUrl":"","linkName":"business4ca.jpg","type":"GRAPHIC","id":"NTFILENJnR9QddXJ3qh8Mj","market":"us","size":1337239},{"description":"","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business5ba.jpg","primary":false,"translateUrl":"","linkName":"business5ba.jpg","type":"GRAPHIC","id":"NTFILEADeN6f2mN57dkP8G","market":"us","size":369138},{"description":"","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business6aa.jpg","primary":false,"translateUrl":"","linkName":"business6aa.jpg","type":"GRAPHIC","id":"NTFILEBvxiQMNusggQVD67","market":"us","size":800532},{"description":"","seq":39,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business7aa.jpg","primary":false,"translateUrl":"","linkName":"business7aa.jpg","type":"GRAPHIC","id":"NTFILECUocDQYBgTYBEQL1","market":"us","size":531376},{"description":"","seq":40,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business8aa.jpg","primary":false,"translateUrl":"","linkName":"business8aa.jpg","type":"GRAPHIC","id":"NTFILEEwMASqoc1wrHjcMw","market":"us","size":672079},{"description":"","seq":41,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/business9ba.jpg","primary":false,"translateUrl":"","linkName":"business9ba.jpg","type":"GRAPHIC","id":"NTFILEDC8ZTwwo1hYXYeCU","market":"us","size":458406},{"description":"","seq":42,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/logoa.jpg","primary":false,"translateUrl":"","linkName":"logoa.jpg","type":"GRAPHIC","id":"NTFILE7LFpFJm4sRuHWs6j","market":"us","size":8428},{"description":"","seq":43,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/marketgraphica.jpg","primary":false,"translateUrl":"","linkName":"marketgraphica.jpg","type":"GRAPHIC","id":"NTFILE6sVAjFwu2pMhepsz","market":"us","size":267174},{"description":"","seq":44,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/pipelinetablea.jpg","primary":false,"translateUrl":"","linkName":"pipelinetablea.jpg","type":"GRAPHIC","id":"NTFILEH4esdY66R6caiNZU","market":"us","size":492960},{"description":"","seq":45,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/ropesgraylogo.jpg","primary":false,"translateUrl":"","linkName":"ropesgraylogo.jpg","type":"GRAPHIC","id":"NTFILEeHxEvNHNMxQ4LN8W","market":"us","size":58835},{"description":"","seq":46,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/treatmentlandscapechartwita.jpg","primary":false,"translateUrl":"","linkName":"treatmentlandscapechartwita.jpg","type":"GRAPHIC","id":"NTFILEGRpkT4wdV6ue5qyk","market":"us","size":181924},{"description":"","seq":47,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/veradermics-certxspecime001.jpg","primary":false,"translateUrl":"","linkName":"veradermics-certxspecime001.jpg","type":"GRAPHIC","id":"NTFILEGeimQkWR4PvUQ8K6","market":"us","size":278923},{"description":"","seq":48,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/veradermics-certxspecime002.jpg","primary":false,"translateUrl":"","linkName":"veradermics-certxspecime002.jpg","type":"GRAPHIC","id":"NTFILEAQhyAmAoMJ2xdvb4","market":"us","size":119822}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2026-01-28 13:00","pubTimestamp":1769576400,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20671134","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828026001651-MANE","pdf_url":"","pub_time":1767934800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"MANE","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/0001628280-26-001651-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/veradermicsincs-1.htm","primary":true,"translateUrl":"","linkName":"veradermicsincs-1.htm","type":"S-1","id":"NTFILEGcg85gkbY8eGoHJj","market":"us","size":2640743},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/exfilingfee.htm","primary":false,"translateUrl":"","linkName":"exfilingfee.htm","type":"EX-FILING FEES","id":"NTFILEFrky7yo9QKbVEPW1","market":"us","size":24813},{"description":"EX-10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/exhibit101-sx1.htm","primary":false,"translateUrl":"","linkName":"exhibit101-sx1.htm","type":"EX-10.1","id":"NTFILEADUPqFYTGZmk62sA","market":"us","size":103116},{"description":"EX-10.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/exhibit102-sx1.htm","primary":false,"translateUrl":"","linkName":"exhibit102-sx1.htm","type":"EX-10.2","id":"NTFILE2MAhaTzQJFufCimf","market":"us","size":29329},{"description":"EX-23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/exhibit231-sx1.htm","primary":false,"translateUrl":"","linkName":"exhibit231-sx1.htm","type":"EX-23.1","id":"NTFILEDWJGGNY2LNp3iuB8","market":"us","size":1820},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business10ba.jpg","primary":false,"translateUrl":"","linkName":"business10ba.jpg","type":"GRAPHIC","id":"NTFILE8x5jU7sUiqy2ZY4G","market":"us","size":360204},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business11ba.jpg","primary":false,"translateUrl":"","linkName":"business11ba.jpg","type":"GRAPHIC","id":"NTFILEC6encK5WgkjCZMzd","market":"us","size":427541},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business12ba.jpg","primary":false,"translateUrl":"","linkName":"business12ba.jpg","type":"GRAPHIC","id":"NTFILE6pZTpzffT6wvcdXK","market":"us","size":395689},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business13ba.jpg","primary":false,"translateUrl":"","linkName":"business13ba.jpg","type":"GRAPHIC","id":"NTFILEB3dJaPtmZku2emXu","market":"us","size":3085536},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business14ba.jpg","primary":false,"translateUrl":"","linkName":"business14ba.jpg","type":"GRAPHIC","id":"NTFILEFEZSgtPdHbymEKnF","market":"us","size":3309624},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business15ba.jpg","primary":false,"translateUrl":"","linkName":"business15ba.jpg","type":"GRAPHIC","id":"NTFILEAaUKjDUSZusYnmNT","market":"us","size":3290382},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business16ba.jpg","primary":false,"translateUrl":"","linkName":"business16ba.jpg","type":"GRAPHIC","id":"NTFILE12StUa8jftW9Wubu","market":"us","size":3769597},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business17ba.jpg","primary":false,"translateUrl":"","linkName":"business17ba.jpg","type":"GRAPHIC","id":"NTFILEBwbN5MCUQAsb3Rt9","market":"us","size":2485777},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business18ba.jpg","primary":false,"translateUrl":"","linkName":"business18ba.jpg","type":"GRAPHIC","id":"NTFILEEKNWCABNcezLdyRY","market":"us","size":1225136},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business19ba.jpg","primary":false,"translateUrl":"","linkName":"business19ba.jpg","type":"GRAPHIC","id":"NTFILEAZp7q3Qc3Yw7BJou","market":"us","size":1234523},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business20ba.jpg","primary":false,"translateUrl":"","linkName":"business20ba.jpg","type":"GRAPHIC","id":"NTFILEFPRbWRQAVY1feNLK","market":"us","size":1048748},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business3ba.jpg","primary":false,"translateUrl":"","linkName":"business3ba.jpg","type":"GRAPHIC","id":"NTFILE34Saj78YdjnEy3tz","market":"us","size":195077},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business4c.jpg","primary":false,"translateUrl":"","linkName":"business4c.jpg","type":"GRAPHIC","id":"NTFILE3cpSWvNnAbSop9iT","market":"us","size":1337239},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business5ba.jpg","primary":false,"translateUrl":"","linkName":"business5ba.jpg","type":"GRAPHIC","id":"NTFILEp46e18YL3KNePsDe","market":"us","size":369138},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business6aa.jpg","primary":false,"translateUrl":"","linkName":"business6aa.jpg","type":"GRAPHIC","id":"NTFILEGCfKUHNvbvFT8yYC","market":"us","size":800532},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business7aa.jpg","primary":false,"translateUrl":"","linkName":"business7aa.jpg","type":"GRAPHIC","id":"NTFILEAeJBAKXZn26TLrW4","market":"us","size":531376},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business8a.jpg","primary":false,"translateUrl":"","linkName":"business8a.jpg","type":"GRAPHIC","id":"NTFILE8AqhobD45YKwpGYE","market":"us","size":672079},{"description":"","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/business9ba.jpg","primary":false,"translateUrl":"","linkName":"business9ba.jpg","type":"GRAPHIC","id":"NTFILE4oVZxbXrXpx3nkCZ","market":"us","size":458406},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/marketgraphica.jpg","primary":false,"translateUrl":"","linkName":"marketgraphica.jpg","type":"GRAPHIC","id":"NTFILEHj2bouw3zmTPqfFo","market":"us","size":267174},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/prospectussummary2ca.jpg","primary":false,"translateUrl":"","linkName":"prospectussummary2ca.jpg","type":"GRAPHIC","id":"NTFILEEjiqHvVikEcjF3Gn","market":"us","size":755504},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/treatmentlandscapechartwita.jpg","primary":false,"translateUrl":"","linkName":"treatmentlandscapechartwita.jpg","type":"GRAPHIC","id":"NTFILEDiBi4EswXJQ8SjNX","market":"us","size":181924},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/veradermics.jpg","primary":false,"translateUrl":"","linkName":"veradermics.jpg","type":"GRAPHIC","id":"NTFILE8A77PinwUnAAB3wQ","market":"us","size":8428}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-01-09 13:00","pubTimestamp":1767934800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.veradermics.com","stockEarnings":[{"period":"1week","weight":0.1008},{"period":"1month","weight":0.3337},{"period":"3month","weight":2.0188},{"period":"ytd","weight":2.0188}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VeraDermics, Incorporated成立于2019年10月5日，最初位于德克萨斯州，后于2021年9月15日转换为特拉华州公司。这家由皮肤科医生创办的晚期临床阶段生物制药公司专注于开发针对普遍存在的美学和皮肤病状况的创新疗法。VeraDermics主要致力于解决影响美国众多个体的模式性脱发（PHL）治疗挑战。公司目前正在推进其主要候选药物VDPHL01，这是一种口服非激素治疗，旨在优化毛发生长，同时最小化与传统疗法相关的副作用。VeraDermics正在进行关键临床试验，以支持监管审批，并通过其针对性的治疗方法，旨在改变PHL的管理方式。","exchange":"NYSE","name":"Veradermics, Inc.","nameEN":"Veradermics, Inc."},"aProfile":null}}}